Scottsdale Interventional Forum (SIF) 2025 (Videos Only)

Advanced Interventional Cardiology, Structural Heart Disease & Cardiovascular Innovation Update

Overview

Scottsdale Interventional Forum (SIF) 2025 is a premier cardiovascular education program focused on the latest advances in interventional cardiology, structural heart disease, coronary revascularization, intravascular imaging, mechanical circulatory support, transcatheter valve therapies, and emerging cardiovascular technologies.

Designed for cardiovascular specialists seeking cutting-edge clinical updates, SIF 2025 delivers expert-led discussions, evidence-based reviews, and practical strategies for managing complex cardiovascular disease. The symposium emphasizes real-world applications of novel therapies, advanced imaging modalities, contemporary interventional techniques, and landmark clinical trials that are shaping the future of cardiovascular care.

Participants gain valuable insights into coronary artery disease management, structural heart interventions, transcatheter valve therapies, plaque modification technologies, antithrombotic strategies, and advanced patient selection approaches for complex cardiovascular procedures.

---

Course Highlights

• Expert-Led Video Sessions
• Advanced Interventional Cardiology Education
• Structural Heart Disease Updates
• Coronary Revascularization Strategies
• Mechanical Circulatory Support Reviews
• OCT & IVUS Imaging Applications
• TAVR & Structural Intervention Updates
• Complex Coronary Intervention Techniques
• Evidence-Based Clinical Trial Reviews
• Contemporary Antiplatelet & Antithrombotic Therapy Updates

---

Learning Objectives

Upon completion of this course, participants will be able to:

• Explain the role of mechanical circulatory support during complex coronary interventions.
• Evaluate emerging coronary stent platforms and regulatory approval pathways.
• Apply modern plaque and coronary calcium modification techniques.
• Compare surgical and percutaneous revascularization strategies in complex coronary disease.
• Integrate advanced cardiovascular imaging into clinical decision-making.
• Utilize OCT and IVUS for lesion assessment and procedural optimization.
• Understand evolving therapies for structural heart disease.
• Apply radial and alternative vascular access techniques safely.
• Evaluate contemporary TAVR indications and patient selection.
• Assess catheter-based therapies for mitral, tricuspid, and pulmonic valve disease.
• Interpret major cardiovascular clinical trial data.
• Optimize antiplatelet and antithrombotic therapy strategies.

---

Major Topics Covered

Complex Coronary Intervention

A major focus of SIF 2025 is the management of complex coronary artery disease.

Topics Include

• Complex PCI techniques
• Multivessel coronary disease
• High-risk coronary intervention
• Chronic total occlusions (CTO)
• Coronary physiology
• Lesion preparation strategies

Participants learn practical approaches for improving procedural outcomes in challenging coronary anatomy.

---

Mechanical Circulatory Support (MCS)

The course reviews the growing role of temporary and advanced mechanical circulatory support systems.

Covered Topics

• Cardiogenic shock management
• Percutaneous ventricular support devices
• Hemodynamic support during PCI
• Patient selection
• Complication management
• Advanced circulatory support strategies

These sessions focus on improving outcomes in critically ill cardiovascular patients.

---

Coronary Calcium & Plaque Modification

Managing heavily calcified coronary lesions remains one of the most challenging areas in interventional cardiology.

Topics Include

• Coronary calcium assessment
• Rotational atherectomy
• Orbital atherectomy
• Intravascular lithotripsy (IVL)
• Specialty balloons
• Lesion preparation techniques

Faculty review modern technologies designed to optimize stent deployment and procedural success.

---

Advanced Coronary Imaging

Imaging-guided intervention is a cornerstone of contemporary PCI practice.

Topics Include

• Optical Coherence Tomography (OCT)
• Intravascular Ultrasound (IVUS)
• Plaque characterization
• Lesion assessment
• Stent optimization
• Imaging-guided PCI

Participants learn how advanced imaging improves diagnostic accuracy and procedural outcomes.

---

Coronary Revascularization Strategies

The conference examines current controversies and decision-making pathways in coronary revascularization.

Discussion Areas

• PCI versus CABG
• Diabetes and coronary disease
• Multidisciplinary heart team decisions
• Complex coronary anatomy
• Guideline-directed revascularization
• Long-term outcome comparisons

Special attention is given to diabetic patients with multivessel coronary artery disease.

---

Structural Heart Disease

SIF 2025 provides extensive updates on structural heart interventions.

Topics Include

• Structural heart disease evaluation
• Patient selection
• Device-based therapies
• Emerging technologies
• Procedural planning
• Long-term outcomes

Participants gain insight into rapidly evolving structural heart treatment options.

---

Transcatheter Aortic Valve Replacement (TAVR)

Dedicated sessions review advances in transcatheter aortic valve therapies.

Topics Include

• Severe aortic stenosis
• Moderate aortic stenosis
• Aortic insufficiency
• Valve selection
• Procedural techniques
• TAVR outcomes

Special emphasis is placed on expanding indications and future applications of TAVR.

---

Mitral Valve Interventions

The symposium explores contemporary catheter-based therapies for mitral valve disease.

Covered Topics

• Degenerative mitral regurgitation
• Functional mitral regurgitation
• Transcatheter edge-to-edge repair
• Mitral valve replacement technologies
• Patient selection
• Imaging guidance

These sessions provide practical updates on modern mitral intervention strategies.

---

Tricuspid & Pulmonic Valve Therapies

Emerging therapies for right-sided valve disease receive dedicated attention.

Topics Include

• Tricuspid regurgitation interventions
• Transcatheter tricuspid therapies
• Pulmonic valve disease
• Novel device technologies
• Clinical trial updates

This rapidly developing field continues to transform structural heart care.

---

Left Atrial Appendage & Cerebral Protection Devices

Additional structural heart topics include:

Covered Areas

• Left atrial appendage closure
• Stroke prevention
• Cerebral embolic protection devices
• Adjunctive procedural technologies
• Patient selection criteria

Participants learn how these devices contribute to improved procedural safety and outcomes.

---

Vascular Access Techniques

Modern access strategies are reviewed throughout the course.

Topics Include

• Radial access
• Alternative vascular access approaches
• Access-site complication prevention
• Procedural efficiency
• Complex intervention access planning

The program highlights best practices for optimizing vascular access safety.

---

Antiplatelet & Antithrombotic Therapy

The conference reviews contemporary evidence supporting cardiovascular pharmacotherapy.

Discussion Areas

• Dual antiplatelet therapy (DAPT)
• Anticoagulation strategies
• High bleeding risk patients
• Post-PCI therapy
• Structural intervention antithrombotic management

Participants gain practical guidance based on the latest clinical trials and guidelines.

---

Landmark Clinical Trials

A key component of SIF 2025 is the review of recent evidence shaping cardiovascular practice.

Topics Include

• Coronary intervention trials
• Structural heart disease trials
• TAVR studies
• Antithrombotic research
• Device therapy outcomes
• Emerging technologies

These sessions help clinicians translate new evidence into everyday patient care.

---

Educational Features

✔ Comprehensive interventional cardiology update

✔ Structural heart disease education

✔ Advanced coronary imaging review

✔ OCT & IVUS applications

✔ Mechanical circulatory support training

✔ TAVR and valve intervention updates

✔ Coronary calcium modification strategies

✔ Evidence-based clinical trial reviews

✔ Antiplatelet and antithrombotic therapy updates

✔ Practical case-based learning

---

Who Should Attend?

This course is ideal for:

• Interventional Cardiologists
• General Cardiologists
• Structural Heart Specialists
• Cardiology Fellows
• Cardiovascular Surgeons
• Cath Lab Physicians
• Nurse Practitioners
• Physician Assistants
• Cath Lab Nurses
• Cardiovascular Technologists
• Allied Health Professionals in Cardiovascular Care

---

Why This Course Stands Out

✔ Focuses on practical interventional cardiology applications

✔ Extensive structural heart disease content

✔ Covers the latest TAVR and valve technologies

✔ Strong emphasis on imaging-guided intervention

✔ Reviews major clinical trials impacting practice

✔ Includes emerging therapies and innovative devices

✔ Evidence-based and clinically relevant curriculum

✔ Ideal for both clinical practice updates and board preparation

✔ Led by nationally recognized cardiovascular experts

✔ Addresses the future direction of cardiovascular intervention

S. No.	Title	Run Time
1	RCA ISR Management: Stent Boost and IVUS Inform DES Over DCB in Elderly Patient	43:51
2	Severe Valvular and Left Main CAD in Frail Patient: DK Crush PCI Strategy and Impella Support	43:52
3	Aortic Valve-in-Valve in Lotus Prosthesis: Technical Challenges and Key Lessons	53:48
4	Chronic Total Occlusion in RCA With Severe Obesity: Retrograde PCI Strategy and IVUS Guidance	36:34
5	Valve-in-Valve in Bicuspid AVR With Dacron Graft: Managing Fracture Limitations	22:59
6	CTO in RCA With Persistent Angina: Dual Guide Approach, IVUS Imaging, and Stenting	39:37
7	Presentation of a Case: Concomitant AF Ablation and LAA Occlusion	36:38
8	Severe MR in a 71-Year-Old: Valve-in-Valve-in-Ring Approach and Deployment Challenges	15:07
9	Women’s Heart Disease: Key Symptom Patterns and Early Detection	07:51
10	Examples of Escalating MCS in STEMI	10:35
11	Mechanical Complications of MI with Cardiogenic Shock: MitraClip Rescue	08:58
12	Vascular Access Challenges with MCS	10:00
13	Cut, Laser, Drill, and Shock	15:28
14	Massive Coronary Thrombosis- Treatment Algorithm and Creative Approaches	16:18
15	The Most Difficult Bifurcations- A Step-by-Step Algorithm	15:32
16	Approaches to Treating Complex Vein Graft Lesions (and the Native Vessels They Supply)	14:57
17	Mitral Transcatheter Edge-to-Edge Repair and Mandatory Mechanical Circulatory Support in Patients with Structural Shock	13:19
18	Novel Use of MitraClip to Treat Aortic Regurgitation	08:52
19	Intravascular Imaging is Now Class 1A in the European Guidelines: How Should US Interventionalists Respond?	22:43
20	Leaflet and Septal Modification during VIV TMVR: Rationale, Tips, and Tricks	15:28
21	Patient Selectiong for Tricuspid Therapies	09:35
22	Optimal TEE and 3D-ICE for Efficient and Effective T-TEER and TTVR	11:00
23	Transcatheter Mitral and Tricuspid Valve in Valve Best Practices	10:57
24	The Next Pillar of Heart Failure Management – the GLP-1 Agonist Phenomenon	13:51
25	Aortic Stenosis and Coronary Artery Disease: A Case Presentation	11:07
26	Coronary Evaluation and Stenting Pre-TAVR: Neither Cath nor PCI Frequently Necessary	08:37
27	Echo Gradients Are Flawed: All BE and SE Valves Do Well!	08:26
28	The Transcatheter Valve Journey: Present and Future	12:56
29	TAV-in-SAV and TAV-in-TAV: ABCDs of the Pre-Procedural Evaluation	13:01
30	Pre TAVR: Cath and Aggressive PCI for All?	11:59
31	The Data Are Clear: Self-Expanding Superior in Smaller Valves	11:35
32	Catheter Based Treatment for Valvular Heart Disease	03:44
33	Advances in Coronary Artery Disease Management	07:28
34	The Growing Field of Heart Failure Management	10:49
35	EVOQUE Tricuspid Valve Replacement	10:38
36	Strategies to Prevent Heart Disease	05:45
37	Managing Stable CAD in Severe Aortic Stenosis: Insights from NOTION and PCI Strategies	12:04
38	Mean Gradient with TEER: Why Higher Gradients Should be Tolerated	10:37
39	Optimal Pharmacologic Management Following LAAO	09:29
40	Left Atrial Appendage Occlusion: Current Advances, Remaining Challenges	10:15
41	M-TEER for Functional MR	13:59
42	Putting LAAO Clinical Trials in Perspective	10:34
43	How to Treat This 75-Year-Old with Severe Degenerative MR	02:10
44	Catheter-Based Therapies for Managing Aortic Insufficiencies	22:27
45	Spare the Blade – M-TEER Today!	04:50
46	The Data Are Favorable, but Can T-TEER Be Democratized?	12:37
47	Mitral Debate – No Way – Surgical Repair Rules Today!	11:58
48	Understanding FDA T-TEER Trials: Are There Enough Pros?	16:03
49	The Role of Transcatheter Tricuspid Valve Replacement: Unsuccessful TTEER with Giant Coaptaion Gap	10:27
50	CT Guidance in TMVR: Lessons Learned and Evolving Imaging Protocols	13:14
51	Tricuspid Regurgitation Impact on TAVR and M-TEER	10:35
52	Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation – Challenges in Trial Design and Interpretation of Outcomes	10:00
53	Should There Be Sex-Based Considerations in the Care of the AS Patient?	13:11
54	Will T-TEER Evolve Similar to M-TEER: an Operator’s Perpsective	11:27
55	Upstream Treatment of AS: Early TAVR, Evolved, TAVR Unload	19:37
56	Back to the Basics: Are Exercise Right Heart Catheterizations Mandatory?	05:37
57	CVD Jeopardy: Cath Lab & ICU Essentials – Arrhythmias, Shock, and Dissection Anticoagulation Pitfalls	17:30
58	The Evolution of HFrEF Therapies	13:52
59	The Emerging Role of Transcatheter Shunts	10:01
60	Evidence-Based Interventions Targeting Valvular Heart Disease in Heart Failure	15:13
61	ModulHeart, Aortix and the Novel Support Devices for Heart Management	15:08
62	Mea Culpa, Mea Culpa, Mea Maxima Culpa – STEMI Management	13:11
63	Left Atrial–Coronary Sinus Shunt Case: Salvaging a Disaster	11:50
64	The Heartbreak of Substance Use	15:23
65	Contemporary Management of STEMI/SHOCK	14:35
66	Cardiac Biomarkers in Acute and Chronic Care	13:17
67	Spontaneous Coronary Artery Dissection: Women & Heart Disease	14:18
68	Equipoise – What’s That – We Did That Study Already	11:07
69	Structural Heart Disease – Evaluation, Management and Postop Care	15:11
70	Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation	VIDEO
71	Cryptogenic Stroke: What’s a PFO?	08:37
72	Surgical vs Transcatheter Approaches in Functional Mitral Regurgitation: Short and Long-Term Data	06:25
73	Failure to Cross: Success Begins with Failure	15:16
74	Left Main Disease: Management Challenges and PCI vs CABG Decision-Making	10:22
75	Making the Cath Lab a Safer Environment: Advances in Radiation Safety	12:55
76	Top Coronary Trials of the Last Year – 2025 Update	14:09
77	Oh, How I Wish That Wouldn’t Have Happened	19:03
78	Will There Be New Indications for the Use of DCB in Coronary Intervention?	13:22
79	CCTA in 2025 – Planning PCI	11:26
80	AMI With Cardiogenic Shock and RV Failure: Escalating to ECMO for Hemodynamic Rescue	02:55
81	Comprehensive Invasive Physiology Suite: From Diagnosis to Outcomes	10:20
82	STEMI vs. Cardiogenic Shock: Understanding the Data on Complete vs. Culprit-Only PCI	13:07
83	Expanding Indication for Intravascular Lithotripsy	14:50
84	Restore EF, Protect III, Protect IV: Where Is the Data Leading?	09:00
85	Shock Outcomes in 2024: Review of Recent Data and Where to Go from There	14:45
86	Acute Cardiogenic Shock Management	10:17
87	STEMI Management: Unloading Before Revascularization – Clinical Implications	10:53
88	Elective Multivessel CAD and the Evidence for Complete Revascularization	09:50